Covidien plc (NYSE: COV), a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced its Puritan Bennettâ„¢ 980 ventilator has received European Economic Area (EEA) CE Mark approval.
The new acute care ventilator from Covidien—designed to be simple, safe and smart—helps enable patients, from neonatal to adult, to breathe more naturally through some of the most innovative breath technology available.
“We are excited to introduce our next-generation acute ventilation platform, the Puritan Bennett 980 ventilator,†said Cristiano Franzi, president, Europe, Covidien. “Building on Covidien’s strong legacy of innovation, the Puritan Bennett 980 ventilator will provide clinicians with a simple, safe and smart way to care for patients.â€
The Puritan Bennett 980 ventilator system is for patients ranging from neonatal to adult. The ventilator system was also approved for commercial distribution in the U.S., Japan and Canada and will be available for sale in those countries as well as the EEA in the coming months.
SOURCEÂ Covidien plc